These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 1846331)
1. Beta-blocking effects of timolol at low plasma concentrations. Kaila T; Huupponen R; Karhuvaara S; Havula P; Scheinin M; Iisalo E; Salminen L Clin Pharmacol Ther; 1991 Jan; 49(1):53-8. PubMed ID: 1846331 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction. Edeki TI; He H; Wood AJ JAMA; 1995 Nov 22-29; 274(20):1611-3. PubMed ID: 7474246 [TBL] [Abstract][Full Text] [Related]
3. The analysis of plasma kinetics and beta-receptor binding and -blocking activity of timolol following its small intravenous dose. Kaila T; Karhuvaara S; Huupponen R; Iisalo E Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):351-7. PubMed ID: 8103764 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study. Nieminen T; Uusitalo H; Mäenpää J; Turjanmaa V; Rane A; Lundgren S; Ropo A; Rontu R; Lehtimäki T; Kähönen M Eur J Clin Pharmacol; 2005 Dec; 61(11):811-9. PubMed ID: 16315032 [TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergic receptors in the elderly are not less sensitive to timolol. Klein C; Gerber JG; Gal J; Nies AS Clin Pharmacol Ther; 1986 Aug; 40(2):161-4. PubMed ID: 3015473 [TBL] [Abstract][Full Text] [Related]
6. Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes. Martinsson A; Lindvall K; Melcher A; Hjemdahl P Br J Clin Pharmacol; 1989 Jul; 28(1):83-94. PubMed ID: 2550046 [TBL] [Abstract][Full Text] [Related]
7. Evidence that beta 1-adrenoceptor activation mediates isoproterenol-stimulated renin secretion in the rat. Churchill PC; Churchill MC; McDonald FD Endocrinology; 1983 Aug; 113(2):687-92. PubMed ID: 6307647 [TBL] [Abstract][Full Text] [Related]
8. Comparative effects of SCH 19927 and timolol on intraocular pressure of conscious rabbits and relative systemic beta-blockade resulting from topical administration. Watkins RW; Cummins DP; Vander Vliet G; Glennon J; Baum T J Ocul Pharmacol; 1985; 1(2):161-8. PubMed ID: 2851634 [TBL] [Abstract][Full Text] [Related]
9. Stimulatory and inhibitory effects of catecholamines on DNA synthesis in primary rat hepatocyte cultures: role of alpha 1- and beta-adrenergic mechanisms. Refsnes M; Thoresen GH; Sandnes D; Dajani OF; Dajani L; Christoffersen T J Cell Physiol; 1992 Apr; 151(1):164-71. PubMed ID: 1313818 [TBL] [Abstract][Full Text] [Related]
10. Quinidine-enhanced beta-blockade during treatment with propafenone in extensive metabolizer human subjects. Mörike KE; Roden DM Clin Pharmacol Ther; 1994 Jan; 55(1):28-34. PubMed ID: 7905369 [TBL] [Abstract][Full Text] [Related]
12. Differential response of beta-adrenergic receptor-mediated heart rate and aortic blood flow acceleration to timolol. Clifton GD; Chandler MH; Pennell AT; McCoy RA; Harrison MR Clin Pharmacol Ther; 1992 Mar; 51(3):296-301. PubMed ID: 1312003 [TBL] [Abstract][Full Text] [Related]
13. Intrathoracic ganglionic beta-adrenergic receptors involved in efferent sympathetic regulation of the canine heart. Armour JA; Butler C Can J Cardiol; 1989; 5(5):275-83. PubMed ID: 2569357 [TBL] [Abstract][Full Text] [Related]
14. Timolol-induced up-regulation of polymorphonuclear leukocyte beta 2-adrenergic receptors in the elderly. Zahniser NR; Bier-Laning CM; Gerber JG; Nies AS Clin Pharmacol Ther; 1989 May; 45(5):469-75. PubMed ID: 2541960 [TBL] [Abstract][Full Text] [Related]
15. Topical beta-adrenergic antagonists and quinidine. A risky interaction. Higginbotham EJ Arch Ophthalmol; 1996 Jun; 114(6):745-6. PubMed ID: 8639090 [No Abstract] [Full Text] [Related]
16. A single dose of three different ophthalmic beta-blockers antagonizes the chronotropic effect of isoproterenol in healthy volunteers. Berlin I; Marcel P; Uzzan B; Millon D; Le Hoang P; Puech AJ Clin Pharmacol Ther; 1987 Jun; 41(6):622-6. PubMed ID: 2884059 [TBL] [Abstract][Full Text] [Related]
17. Transdermal timolol: beta blockade and plasma concentrations after application for 48 hours and 7 days. McCrea JB; Vlasses PH; Franz TJ; Zeoli L Pharmacotherapy; 1990; 10(4):289-93. PubMed ID: 2388875 [TBL] [Abstract][Full Text] [Related]
18. Timolol metabolism in human liver microsomes is mediated principally by CYP2D6. Volotinen M; Turpeinen M; Tolonen A; Uusitalo J; Mäenpää J; Pelkonen O Drug Metab Dispos; 2007 Jul; 35(7):1135-41. PubMed ID: 17431033 [TBL] [Abstract][Full Text] [Related]
19. [Exogenous adrenergic stimulation by intravenous infusions of isoproterenol and blood levels of cyclic AMP before and after beta-blocking in humans]. Nami R; Pizzuti M; Nardi PL; D'Ascenzo G; Maioli E; Gennari C Boll Soc Ital Cardiol; 1980; 25(7):763-8. PubMed ID: 6115658 [No Abstract] [Full Text] [Related]
20. Role of cyclic AMP-dependent protein kinase in the diminished beta adrenergic responsiveness of vascular smooth muscle with increasing age. Deisher TA; Mankani S; Hoffman BB J Pharmacol Exp Ther; 1989 Jun; 249(3):812-9. PubMed ID: 2543812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]